Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Xvivo Perfusion AB (OTC: XVIPF).

Full DD Report for XVIPF

You must become a subscriber to view this report.


Recent News from (OTC: XVIPF)

Xvivo Perfusion AB 2018 Q2 - Results - Earnings Call Slides
The following slide deck was published by Xvivo Perfusion AB in conjunction with their 2018 Q2 earnings Read more ...
Source: SeekingAlpha
Date: July, 20 2018 13:54
Xvivo Perfusion AB 2018 Q1 - Results - Earnings Call Slides
The following slide deck was published by Xvivo Perfusion AB in conjunction with their 2018 Q1 earnings Read more ...
Source: SeekingAlpha
Date: April, 26 2018 14:20
Xvivo Perfusion AB 2017 Q4 - Results - Earnings Call Slides
The following slide deck was published by Xvivo Perfusion AB in conjunction with their 2017 Q4 earnings Read more ...
Source: SeekingAlpha
Date: February, 12 2018 12:44
Xvivo Perfusion AB 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by Xvivo Perfusion AB in conjunction with their 2017 Q3 earnings Read more ...
Source: SeekingAlpha
Date: October, 27 2017 14:32

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-12N/A14.23N/AN/A0
2018-12-11N/A14.23N/AN/A0
2018-12-10N/A14.23N/AN/A0
2018-12-07N/A14.23N/AN/A0
2018-12-06N/A14.23N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-11-21100100100.0000Short
2018-11-13200200100.0000Short
2018-09-06100100100.0000Short
2018-08-242525100.0000Short
2018-08-103,0053,005100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on XVIPF.


About Xvivo Perfusion AB (OTC: XVIPF)

Logo for Xvivo Perfusion AB (OTC: XVIPF)

XVIVO is a medical technology company focused on developing optimized solutions for organ, tissue and cell preservation in connection with transplantation. Our mission is to increase the survival rates of patients awaiting transplantation by providing more effective, clinically proven innovative products that both increase the availability of acceptable donors organs and improve survival after transplantation. We are committed to provide our customers with solutions and systems that can improve the transplant process outcome, facilitate the work for the transplant team, and enhance the long term outcomes and quality of life of the transplant recipient.

 

Contact Information

 

 

Current Share Structure

     



    Daily Technical Chart for (OTC: XVIPF)

    Daily Technical Chart for (OTC: XVIPF)


    Stay tuned for daily updates and more on (OTC: XVIPF)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (OTC: XVIPF)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in XVIPF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of XVIPF and does not buy, sell, or trade any shares of XVIPF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/